Total Payments
$3,993
2024 Payments
$515.30
Companies
21
Transactions
210
Medicare Patients
124
Medicare Billing
$31,850
Payment Breakdown by Category
Food & Beverage$3,957 (99.1%)
Education$35.16 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,957 | 208 | 99.1% |
| Education | $35.16 | 2 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,549 | 84 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $358.07 | 9 | $0 (2024) |
| Lundbeck LLC | $353.42 | 23 | $0 (2023) |
| ITI, Inc. | $239.58 | 14 | $0 (2023) |
| Supernus Pharmaceuticals, Inc. | $208.49 | 8 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $166.69 | 6 | $0 (2024) |
| Allergan, Inc. | $154.24 | 20 | $0 (2020) |
| Vanda Pharmaceuticals Inc. | $148.16 | 6 | $0 (2024) |
| Corium, LLC | $146.37 | 8 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $90.54 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $515.30 | 27 | ABBVIE INC. ($160.66) |
| 2023 | $1,112 | 58 | ABBVIE INC. ($299.80) |
| 2022 | $692.04 | 34 | ABBVIE INC. ($373.42) |
| 2021 | $889.76 | 44 | AbbVie Inc. ($715.50) |
| 2020 | $312.99 | 29 | Allergan, Inc. ($124.25) |
| 2019 | $255.91 | 11 | Janssen Pharmaceuticals, Inc ($149.63) |
| 2018 | $198.21 | 6 | Otsuka America Pharmaceutical, Inc. ($86.96) |
| 2017 | $16.15 | 1 | Greer Laboratories, Inc. ($16.15) |
All Payment Transactions
210 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: PSYCHIATRY | ||||||
| 10/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $22.11 | General |
| Category: PSYCHIATRY | ||||||
| 10/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 10/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.93 | General |
| Category: NEUROSCIENCE | ||||||
| 09/25/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $24.59 | General |
| Category: Neuropsychiatry | ||||||
| 08/28/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $28.69 | General |
| Category: Neuropsychiatry | ||||||
| 08/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: NEUROSCIENCE | ||||||
| 07/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: NEUROSCIENCE | ||||||
| 07/10/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: PSYCHIATRY | ||||||
| 06/26/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: PSYCHIATRY | ||||||
| 06/18/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $38.72 | General |
| Category: SCHIZOPHRENIA | ||||||
| 06/05/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: ADHD | ||||||
| 05/29/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 05/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: NEUROSCIENCE | ||||||
| 05/20/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: NEUROSCIENCE | ||||||
| 02/27/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 02/27/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 02/14/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), REXULTI | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: PSYCHIATRY | ||||||
| 02/07/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: PSYCHIATRY | ||||||
| 02/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: NEUROSCIENCE | ||||||
| 01/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.24 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 51 | 194 | $25,640 | $12,457 |
| 2022 | 2 | 38 | 155 | $22,370 | $10,739 |
| 2021 | 2 | 35 | 116 | $16,840 | $8,653 |
Total Patients
124
Total Services
465
Medicare Billing
$31,850
Procedure Codes
7
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2023 | 19 | 96 | $12,480 | $5,670 | 45.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 15 | 48 | $7,660 | $3,971 | 51.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 17 | 50 | $5,500 | $2,816 | 51.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 19 | 74 | $11,840 | $6,011 | 50.8% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2022 | 19 | 81 | $10,530 | $4,728 | 44.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 18 | 60 | $9,560 | $5,005 | 52.4% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2021 | 17 | 56 | $7,280 | $3,649 | 50.1% |
About Dr. Mohammad Naeem, M.D
Dr. Mohammad Naeem, M.D is a Psychiatry healthcare provider based in Mandeville, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/09/2012. The National Provider Identifier (NPI) number assigned to this provider is 1811253420.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mohammad Naeem, M.D has received a total of $3,993 in payments from pharmaceutical and medical device companies, with $515.30 received in 2024. These payments were reported across 210 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($3,957).
As a Medicare-enrolled provider, Naeem has provided services to 124 Medicare beneficiaries, totaling 465 services with total Medicare billing of $31,850. Data is available for 3 years (2021–2023), covering 7 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Mandeville, LA
- Active Since 04/09/2012
- Last Updated 05/16/2018
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1811253420
Products in Payments
- VRAYLAR (Drug) $1,704
- SPRAVATO (Drug) $358.07
- CAPLYTA (Drug) $330.12
- REXULTI (Drug) $270.08
- ABILIFY MAINTENA (Drug) $234.30
- QELBREE (Drug) $208.49
- Azstarys (Drug) $146.37
- HETLIOZ (Drug) $109.44
- AUSTEDO (Drug) $83.05
- INGREZZA (Drug) $74.93
- Auvelity (Drug) $73.13
- ORALAIR (Biological) $70.25
- ARISTADA (Drug) $64.02
- TRINTELLIX (Drug) $62.76
- FANAPT (Drug) $38.72
- NEUROSTAR TMS THERAPY (Device) $35.35
- Dyanavel XR (Drug) $20.38
- Grastek (Drug) $18.80
- Oralair (Drug) $16.15
- ABILIFY ASIMTUFII (Drug) $15.73
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Mandeville
William Colomb, M.d, M.D
Psychiatry — Payments: $95,019
Psychiatry $95,019
Dr. Hyon Kim, M.d, M.D
Psychiatry — Payments: $3,462
Psychiatry $3,462
Garic Grisbaum, M.d, M.D
Psychiatry — Payments: $2,672
Psychiatry $2,672
Dr. Geraldine Payne, M.d, M.D
Psychiatry — Payments: $670.05
Psychiatry $670.05
Leanne Truehart, Md, MD
Psychiatry — Payments: $563.50
Psychiatry $563.50
Lauren Larose, M.d, M.D
Psychiatry — Payments: $442.26
Psychiatry $442.26